You are here

Clinical Practice

 

Scientists from NUST MISIS have developed “living bandages” created from nanofibers that are capable of accelerating the regeneration of damaged tissue. Findings are published in Applied Surface Science.

Scientists at Imperial College London have developed and tested an organ-on-a-chip showing how pathogens like hepatitis B interact with artificial human organs. Findings were published in Nature Communications.

Researchers have developed a list of recommended changes to international guidelines for the development of clinical trials to gain insights on the impact of treatment on participants and their quality of life. Finding were published in the Journal of the American Medical Association.

Researchers from the Medical University of South Carolina (MUSC Health) have found using a mechanical initial specimen diversion device (ISDD) with additional staff education could reduce contaminated blood cultures by four-fold.

Remote patient monitoring may not improve a half-dozen clinical outcomes, according to a study published in Nature Digital Medicine.

 

Recent Headlines

Robots improve postop outcomes after esophageal surgery

Robotic surgeries could be the way of the future according to researchers at Allina Health. In a recent study published in Diseases of the Esophagus, researchers tested the safety and effectiveness of robotic assisted transhiatal esophagectomy (RATE) on patients.

Nanotechnology test identifies Zika in minutes

Detecting Zika currently requires blood samples to be refrigerated and shipped to a laboratory for tests, delaying treatment and care to those in rural areas. Researchers from Washington University published a study in Advanced Biosystems that details a new technology capable of delivering Zika test results in minutes.

Smartphone spectrometer detects diseases as accurately as lab equipment

Researchers at the University of Illinois at Urbana-Champaign have utilized smartphone technology to develop a spectral transmission-reflectance-intensity (TRI) analyzer. The technology attaches to a smartphone and can analyze samples of blood, urine and saliva just as well as clinical instruments.

Video games can reduce gray matter in hippocampus

Playing video game can reduce the amount of gray matter in the hippocampus region of the brain by using spatial learning, navigation and memory. In a study published in Molecular Psychiatry, researchers evaluated which types of games affect the brain.

Device repurposes cells, healing organs without additional treatment

Described in the recent issue of Nature Nanotechnology, a technology called Tissue Nanotransfection (TNT) technology has shown an ability to transform skin cells into other types of cells with 98 percent accuracy, with the potential ability to save failing organs.

Watson AI provides comprehensive, personalized cancer reports

IBM's artificial intelligence platform Watson is being trained to help cancer patients receive more personalized care by identifying the specific genetic mutations causing their disease. With Watson's reports, healthcare providers will be able to develop and administer therapies to directly treat each patient.

Brain implant delivers ultrasonic waves to brain treating cancer, Alzheimer’s

A recent study published in Advanced Healthcare Materials outlines a new ceramic skull implant capable of delivering ultrasound treatments.

Reducing brain injury, sensory damage following cardiac arrest

Those who have experienced cardiac arrest face long-term health effects related to brain activity. Recent research examined the impact of such events, including the deprivation of oxygen to the brain, and subsequent resuscitation efforts.

Non-invasive technology predicts onset of asthma attacks

Predicting the onset of an asthma attack by identifying symptoms early could improve outcomes in children with high risk asthma. Researchers have evaluated a new non-invasive technological approach to analyze lung sounds in young patients to hopefully predict the onset of an attack. Findings are published in Respirology.

Philips wearable blue light device relieves psoriasis symptoms in 84% of users

Royal Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its wearable therapy device, BlueControl, to treat people with mild psoriasis. Philips aims to assist people in easily treating their psoriasis with a wearable device that can be used at home.

Pages